Professor Jenkins leads the Margaret Turner Warwick Centre for Fibrosing Lung Diseases at the National Heart and Lung Institute. His clinical and research focus is on interstitial lung disease, and pulmonary fibrosis in particular.
His research focuses on the mechanisms by which injury leads to scarring in the lung. Lung scarring is the central process leading to disability and death in people with idiopathic pulmonary fibrosis. It also occurs in diseases such as chronic asthma where it promotes airway remodelling and impaired lung function.
Professor Jenkins’ research work is funded by the National Institute of Health Research and organisations such as the Wellcome Trust, the Medical Research Council, charities and pharmaceutical companies.
He is leading the UK’s first James Lind Alliance Research Priority Setting Partnership for Pulmonary Fibrosis starting 2020. He was a founding trustee of the charity.